An Electron Donor‐Acceptor Structured Rhenium(I) Complex Photo‐sensitizer Evokes Mutually Reinforcing "Closed‐Loop" Ferroptosis and Immunotherapy

Qingyan Ren,Haobing Wang,Dan Li,Anyi Dao,Jiajun Luo,Deliang Wang,Pingyu Zhang,Huaiyi Huang
DOI: https://doi.org/10.1002/adhm.202304067
IF: 10
2024-04-11
Advanced Healthcare Materials
Abstract:The hypoxic microenvironment of solid tumors severely lowers the efficacy of oxygen‐dependent photodynamic therapy (PDT). The development of hypoxia‐tolerant photosensitizers for PDT is an urgent requirement. In this study, we report a novel rhenium complex (Re‐TTPY) to develop a "closed‐loop" therapy based on PDT‐induced ferroptosis and immune therapy. Due to its electron donor‐acceptor (D‐A) structure, Re‐TTPY undergoes energy transfer and electron transfer processes under 550 nm light irradiation, and displays hypoxia‐tolerant type I/II combined PDT capability, which can generate 1O2, O2·−, and ·OH simultaneously. Furthermore, the reactive oxygen species (ROSs) lead to the depletion of 1,4‐dihydronicotinamide adenine dinucleotide (NADH), glutathione peroxidase 4 (GPX4) and glutathione (GSH). As a result, ferroptosis occurs in cells, simultaneously triggers immunogenic cell death (ICD) and promotes the maturation of dendritic cells (DCs) and infiltration of T cells. The release of interferon‐γ (IFN‐γ) by CD8+ T cells downregulates the expression of GPX4, further enhances the occurrence of ferroptosis, thereby forming a mutually reinforcing "closed‐loop" therapeutic approach. This article is protected by copyright. All rights reserved
nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials
What problem does this paper attempt to address?